Disease expression in patients with primary ciliary dyskinesia (PCD), CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI)

M. Cohen-Cymberknoh, N. Simanovski, N. Hiller, A. Gileles Hillel, D. Shoseyov, E. Kerem (Jerusalem, Israel)

Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Session: Mechanism and monitoring of airway diseases
Session type: Oral Presentation
Number: 360
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Cohen-Cymberknoh, N. Simanovski, N. Hiller, A. Gileles Hillel, D. Shoseyov, E. Kerem (Jerusalem, Israel). Disease expression in patients with primary ciliary dyskinesia (PCD), CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI). Eur Respir J 2011; 38: Suppl. 55, 360

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systematic review of lung clearance index (LCI) in non-cystic fibrosis (CF), non-primary ciliary dyskinesia (PCD) bronchiectasis (Bx)
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


The prevalence of primary ciliary dyskinesia (PCD) in adult patients with bronchiectasis in Dnipro (Ukraine)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Bacterial biofilms in bronchiectasis of primary ciliary dyskinesia (PCD) in comparison with cystic fibrosis (CF)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD).
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Lung function in different ethnic groups in children with primary ciliary dyskinesia (PCD)
Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects
Year: 2013

Treatments for primary ciliary dyskinesia (PCD) in children across Europe
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008

Genetic risk factors for laterality defects and congenital heart disease (CHD) in patients with primary ciliary dyskinesia (PCD)
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Do patients suffering from heart failure (HF) and chronic obstructive pulmonary disease (COPD) tolerate beta blocker (BB) treatment?
Source: Annual Congress 2011 - Comorbidities and management in primary care
Year: 2011



Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 125s
Year: 2001

Noninvasive ventilation (NIV) after lung resection (LR) to prevent respiratory complications (RCs) in COPD patients (pts) (POPVNI trial)
Source: Annual Congress 2011 - Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations
Year: 2011

Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010


Mental health during COVID-19 in Dutch adolescents and adults with cystic fibrosis (CF) or primary ciliary dyskinesia (PCD) and their caregivers
Source: Virtual Congress 2021 – Psychological and behavioural issues in respiratory care
Year: 2021



Pulmonary care of primary ciliary dyskinesia (PCD)
Source: Eur Respir J 2005; 26: Suppl. 49, 628s
Year: 2005

HRQoL in adult patients with Eisenmenger syndrome (ES) compared to patients with primary pulmonary hypertension (PPH) or post-embolic pulmonary hypertension (PEPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 455s
Year: 2002

Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 70s
Year: 2006

COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012

Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008

Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Lung clearance index is stable in most primary ciliary dyskinesia (PCD) patients managed in a specialist centre: A pilot study
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016